Rhino Biotech Limited (RBRXF)
OTHER OTC:RBRXF
US Market

Rhino Biotech Limited (RBRXF) Financial Statements

0 Followers

Rhino Biotech Limited Financial Overview

Rhino Biotech Limited's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Rhino Biotech Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 07Sep 07Jun 07Mar 07Dec 06
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -12.48K$ -323.24K$ -375.96K$ -103.02K$ -176.59K
EBITDA$ -8.66K$ -319.41K$ -372.13K$ -99.19K$ -172.81K
Net Income Common Stockholders$ -583.97K$ -316.77K$ -373.22K$ -98.72K$ -170.50K
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 566.70K$ 931.60K$ 189.08K$ 370.94K$ 515.31K
Total Assets$ 647.90K$ 1.04M$ 322.50K$ 438.75K$ 585.03K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -566.70K$ -931.60K$ -189.08K$ -370.94K$ -515.31K
Total Liabilities$ 20.22K$ 16.83K$ 15.90K$ 9.12K$ 56.68K
Stockholders Equity$ 627.68K$ 1.02M$ 306.61K$ 429.63K$ 528.35K
Cash Flow-
Free Cash Flow$ -364.90K$ -257.48K$ -181.87K$ -144.37K$ -122.68K
Operating Cash Flow$ -364.90K$ -257.48K$ -181.87K$ -144.37K$ -123.02K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 335.00
Financing Cash Flow$ 0.00$ 1.00M$ 0.00$ 0.00$ 0.00
Currency in USD

Rhino Biotech Limited Earnings and Revenue History

Rhino Biotech Limited Debt to Assets

Rhino Biotech Limited Cash Flow

Rhino Biotech Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis